Side-by-side financials for ALEC and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALEC | RVMD |
|---|---|---|
| Market cap | - | $32.71 B |
| US-listed rank | - | #439 |
| Revenue (latest FY) | $21.05M | $0.00 |
| Net income (latest FY) | -$143.00M | -$1.13B |
| Net margin | -679.5% | - |
| SEC filings | 581 | 782 |
In their latest fiscal years, Alector, Inc. reported $21.05M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Alector, Inc. and Revolution Medicines, Inc., or browse the full rankings.